Bloomington Company Expanding Services
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowBloomington-based AB BioTechnologies Inc. has announced it is expanding operations. The pharmaceutical contract service provider says its services will now include pre-clinical manufacturing at its Monroe County facility.
The company says it already has the expertise and ability to conduct early-stage development work for new drug candidates through what it calls Good Laboratory Practice manufacturing that supports pre-clinical and toxicology studies. AB BioTechnologies says the expansion will not involve any significant investment or personnel growth.
"This is a natural progression for our company, given our existing pharmaceutical development capabilities," said Jeff Schwegman, chief executive officer of AB BioTechnologies. "We are constantly looking for ways to make outsourcing easier for our clients and feel this expansion will help streamline the path to the clinic."
The company says it has begun implementing processes and expects a successful completion of a third-party audit by the end of the third quarter of 2016.